February 21, 2017
February 21, 2017 —
A paradigm-changing study in the journal Nature by cancer researchers and computer scientists at UC San Diego and other institutions found that short fragments of circular DNA that encode cancer genes are far more common in cancer cells than previously believed.
February 17, 2017
February 17, 2017 —
An international research team, led by principal investigator Elizabeth A. Winzeler, PhD, professor in the pediatric division of host-microbe systems and therapeutics at University of California San Diego School of Medicine, and colleagues have received a three-year, $4.7 million supplemental grant from the Bill & Melinda Gates Foundation to advance their development of improved therapies for malaria eradication and elimination.
February 16, 2017
February 16, 2017 —
Methicillin-resistant Staphylococcus aureus (MRSA) is a bacterial scourge that is resistant to most common antibiotics and thus difficult to treat, particularly in children where it commonly causes complicated skin and skin structure infections. In a randomized, controlled clinical trial — the first of its kind — a multi-institution research team reports that daptomycin, part of a new class of antibiotics currently approved only for use in adults, is effective and well-tolerated in children.
February 15, 2017
February 15, 2017 —
A team of 18 University of California San Diego School of Medicine and Moores Cancer Center researchers has developed a new tool to analyze an often overlooked aspect of cancer genetics — an alteration that results in the loss or gain in a copy of a gene. This change, known as somatic copy-number alterations, may be key to disease progression and might offer new therapeutic approaches for ovarian cancer and other malignancies.
February 14, 2017
February 14, 2017 —
Sandra Horning, MD, Chief Medical Officer and executive vice president of global development for Roche and Genentech, a member of the Roche Group, has been named the 2017 recipient of the Duane Roth Memorial Award, which will be presented February 16 at the annual Industry/Academia Translational Oncology Symposium at UC San Diego Moores Cancer Center.
February 9, 2017
February 9, 2017 —
Think you have an idea that will change health care but need the means to bring your innovation to fruition? Register for UC Health Hack, a two-day interdisciplinary hackathon that will bring students, physicians, researchers, industry professionals and community members together to grapple with integrative medicine and global health issues in a fast-paced competition.
February 9, 2017
February 9, 2017 —
Researchers at University of California San Diego School of Medicine, with colleagues at Rady Children’s Institute for Genomic Medicine and in London and Singapore, have conducted novel whole genome sequencing of a family in which two of four children were affected by Kawasaki disease. They have identified plausible gene variants that predispose some children to developing the disease.
February 7, 2017
February 7, 2017 —
UC San Diego Health and the San Diego Padres reached an agreement on a multi-year partnership to become the Major League Baseball team’s Official Health Care Provider.
February 6, 2017
February 6, 2017 —
Research conducted at University of California San Diego School of Medicine found that current trends in diagnostic coding for patient risk scores will lead to Medicare overpaying Medicare Advantage (MA) plans substantially through 2026-likely to the tune of hundreds of billions of dollars. The study is published in the February issue of Health Affairs.
February 6, 2017
February 6, 2017 —
In a mouse study, researchers at University of California San Diego School of Medicine have identified a protein that inhibits the enzyme that breaks down bilirubin in newborns. Methods that block this inhibitor, and thus restore the enzyme’s activity, could provide a new therapeutic approach for preventing or treating severe newborn jaundice. The study is published February 6, 2017 by the Proceedings of the National Academy of Sciences.
